Whitfield Dianne C.

CIK 00018395161 companyIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001839516

Recent Transactions

42 trades

Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-01-02$80.71/sh−8,122→ 25,121 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-01-02$80.09/sh−5,715→ 33,243 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-01-02$82.93/sh−893→ 23,393 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-01-02$81.90/sh−835→ 24,286 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-12-16$80.10/sh−7,397→ 38,958 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-20$50.11/sh−2,137→ 46,355 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-19$47.40/sh−2,259→ 48,492 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-18$46.29/sh−2,315→ 50,751 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-15−7,248→ 14,497 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-15−7,175→ 21,527 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-15−4,462→ 4,463 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-15+18,885→ 53,066 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2025-03-05+30,628→ 30,628 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-05+20,089→ 20,089 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-03-18$30.60/sh−4,314→ 34,181 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-03-15−7,248→ 21,745 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-03-15+11,711→ 38,495 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-03-15−4,463→ 8,925 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2024-03-07+42,500→ 42,500 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-03-07+28,702→ 28,702 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-11-30$16.31/sh−8,355→ 26,784 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-11-29+23,920→ 35,139 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2023-11-29−23,920→ 0 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-23$12.15/sh−345→ 11,219 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-22$12.64/sh−333→ 11,564 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-21$12.89/sh−326→ 11,897 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-20$12.61/sh−333→ 12,223 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-17$13.28/sh−316→ 12,556 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-16$13.43/sh−313→ 12,872 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2023-03-15−4,462→ 13,388 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-15+4,462→ 13,185 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2023-03-08+28,993→ 28,993 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2023-03-08+42,802→ 42,802 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2022-12-02$16.90/sh−1,154→ 8,723 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2022-12-01$16.75/sh−1,165→ 9,877 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2022-11-30$16.50/sh−1,182→ 11,042 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2022-11-29−10,251→ 23,920 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2022-11-29+10,251→ 12,224 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2022-03-09+60,846→ 60,846 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2022-03-09+17,850→ 17,850 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2022-03-09+34,171→ 34,171 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2021-01-07+89,368→ 89,368 total

Companies

Tarsus Pharmaceuticals, Inc.
Chief Human Resources Officer
$TARS

Recent Filings

Address

C/O TARSUS PHARMACEUTICALS, INC. 15440 LAGUNA CANYON ROAD, SUITE 160

IRVINE, CA, 92618

View on SEC.gov